Безопасен ли pentapeptide-61 при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
Related ingredients
Frequently asked questions
- Безопасен ли pentapeptide-61 при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
- Безопасен ли pentapeptide-61 при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity or mechanism for pentapeptide-61 in SCCS/CIR/ECHA or peer-reviewed literature. No harmonised classification. Given expected low dermal absorption of short peptides, systemic exposure to lactating parent and transfer into breast milk is considered negligible based on available information.
- Безопасен ли pentapeptide-61 для кожи малыша?
- No infant-specific safety or developmental toxicity data identified. Peptides this size are generally poorly absorbed through intact adult skin (adult exposure rated 0), but infant skin has higher permeability; following guidance, exposure for baby skin is increased by +1 (to 1) due to possible measurable absorption in infants. No mechanistic or hazard evidence for reproductive/developmental effects specific to infants was found.
- Как VeriMom оценивает pentapeptide-61?
- VeriMom оценивает pentapeptide-61 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы pentapeptide-61 при беременности?
- См. наш список безопасных альтернатив pentapeptide-61 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.